AF
TEVA icon

AGP Franklin’s Teva Pharmaceuticals TEVA Stock Holding History

AGP Franklin’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-124,543
Closed -$2.09M – 93
2025
Q2 		$2.09M Buy
124,543
+75
+0.1% +$1.21K 1.1% 38
2025
Q1 		$1.69M Buy
124,468
+112,410
+932% +$2.01M 1.04% 41
2024
Q4 		$266K Buy
+12,058
New +$219K 0.16% 74

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

AGP Franklin's TEVA Position: Q3 2025 in Review

AGP Franklin sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 124,543 shares — an estimated $2.09M sold.

AGP Franklin first reported a position in TEVA in Q4 2024 and held it in 3 quarters. The position peaked at $2.09M in Q2 2025. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • AGP Franklin reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • AGP Franklin sold 124,543 Teva Pharmaceuticals shares in Q3 2025, an estimated $2.09M.
  • AGP Franklin first reported a position in Teva Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • AGP Franklin's Teva Pharmaceuticals position peaked at $2.09M in Q2 2025.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on AGP Franklin's 13F filing for Q3 2025, filed 3 Nov 2025.